Basic Phenergan Information

• INN (International Nonproprietary Name): Promethazine hydrochloride
• Brand Names Available In United Kingdom: Phenergan (tablets 25mg, blister packs; other international brands include Avomine, Lergigan)
• ATC Code: R06AD02
• Forms & Dosages: Tablets 10mg and 25mg; Elixir (syrup) 1mg/mL in 100mL bottle; Suppositories reported at 12.5mg, 25mg, 50mg though availability varies
• Manufacturers In United Kingdom: Opella Healthcare UK Limited
• Registration Status In United Kingdom: Marketed and regulated by national agencies (Phenergan listed for UK market)
• OTC / Rx Classification: Prescription medication (Rx) in most countries, including the UK

Latest Research Highlights

Patients and clinicians ask whether new evidence changes routine use of Phenergan.

Recent UK and EU reports from 2022–2025 have focused on pharmacovigilance and pragmatic comparisons rather than large superiority trials.

Regulatory surveillance by national agencies continues to flag longstanding safety concerns: respiratory depression in infants under two, pronounced sedation in older adults, and anticholinergic harms in multimorbid patients.

Smaller UK randomised trials and observational travel‑clinic analyses confirm promethazine’s efficacy for motion sickness and short‑term antiemetic use, without a clear advantage over cyclizine or dimenhydrinate for routine allergy control.

EU post‑marketing analyses show a stable adverse‑event pattern overall, with increased adverse reporting from online‑sourced supplies in some datasets.

MHRA Yellow Card reporting highlights upticks in sedation and confusion where promethazine is combined with other CNS depressants.

Product data anchor points include ATC R06AD02 and available forms/doses such as Phenergan tablets 25mg and elixir 1mg/mL.

Clinical Effectiveness In The UK

Patients commonly want fast relief for nausea, travel sickness and allergic symptoms.

NHS experience places promethazine (Phenergan, INN promethazine hydrochloride) as an effective short‑term antihistamine with strong sedative properties.

Primary‑care audits report rapid symptomatic relief for motion sickness and nausea but frequent sedative effects that limit chronic use.

Patient‑reported outcomes via NHS portals show high rates of symptom control for vomiting and motion sickness and repeated complaints of daytime drowsiness.

Secondary‑care use for pre‑operative sedation remains occasional and usually adjunctive rather than routine.

• Patient‑Reported Outcomes:
• High relief for nausea and motion sickness symptoms.
• Frequent daytime drowsiness affecting work and driving.
• Occasional dry mouth, blurred vision and constipation.

Typical adult dosing used in practice includes 25mg for motion sickness and 10–25mg at night for allergic symptoms, consistent with product information and NHS prescribing patterns.

Indications And Expanded Uses

People ask whether Phenergan is only for allergy or useful for other problems.

MHRA‑authorised UK indications centre on symptomatic relief of allergic conditions, motion sickness, and short‑term sedation or antiemetic use, and NHS practice follows these uses.

Common off‑label uses in palliative care and some private clinics include night‑time insomnia adjuncts and palliative antiemesis when other agents are unsuitable; these uses are always documented and justified clinically.

Use in children is strictly limited: promethazine is not recommended under two years because of fatal respiratory depression risk.

When used off‑label in hospices, doses are tailored and supervised by specialists with clear clinical rationale documented.

Composition And Brand Landscape

Patients often ask which brands and formulations are available in the UK.

The active ingredient is promethazine hydrochloride (INN), marketed in the UK mainly as Phenergan tablets 25mg supplied in blister packs by Opella Healthcare UK Limited.

Internationally, promethazine appears under brand names such as Avomine, Lergigan and others, and in various forms including tablets, elixir syrup 1mg/mL and occasional suppositories.

The ATC classification R06AD02 identifies promethazine among systemic antihistamines and is a useful anchor for formularies and search optimisation.

High‑street chains and online pharmacies list branded and unbranded options; product choice often depends on formulation preference and pack size.

Contraindications And Special Precautions

Safety is the top concern for patients starting promethazine.

Absolute contraindications include hypersensitivity to promethazine or phenothiazine derivatives and children under two years because of the risk of fatal respiratory depression.

Relative contraindications that require caution or monitoring include elderly patients, severe hepatic or renal impairment, history of seizures, narrow‑angle glaucoma, prostatic hypertrophy and urinary retention.

Practical lifestyle advice is essential: avoid driving or operating machinery while sedated and avoid alcohol or other CNS depressants taken concurrently.

Pregnancy and breastfeeding require specialist risk–benefit review before prescribing or dispensing.

• Absolute Contraindications:
• Hypersensitivity to promethazine/phenothiazines.
• Children under 2 years.
• Relative Contraindications:
• Elderly, significant liver or kidney disease, epilepsy, glaucoma, prostatic enlargement.

A highlighted caution for paediatrics and older adults helps pharmacists and prescribers reduce avoidable harm.

Dosage Guidelines

Patients ask: how much Phenergan should I take and when?

Standard adult NHS regimens use 10–25mg for allergic symptoms (for example 10mg two to three times daily or 10–25mg at night) and 25mg for motion sickness given the night before or 1–2 hours before travel.

For nausea and vomiting, antiemetic dosing is commonly 25–50mg, repeatable after 4–6 hours if required.

Paediatric dosing avoids use under two years and for older children uses lower amounts such as 5–15mg at night or 12.5–25mg for motion sickness, with specialist weight‑based calculation where needed.

Elderly patients should receive dose reductions and close monitoring for sedation and hypotension.

When to reduce dose: elderly, hepatic/renal impairment, concurrent CNS depressants — follow the ‘when to reduce dose’ checklist in dispensing notes.

Interactions Overview

Many patients worry about mixing medicines with Phenergan.

Promethazine potentiates central nervous system depression with alcohol, opioids, benzodiazepines, sedating antidepressants and certain antipsychotics, increasing sedation and respiratory risk.

Anticholinergic load rises when combined with tricyclic antidepressants or other antimuscarinic drugs, worsening dry mouth, urinary retention and confusion, especially in older adults.

Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI therapy increases the risk of adverse effects and needs specialist review.

Caffeine or tea will not reliably reverse anticholinergic sedation and may mask tiredness rather than eliminate risk.

Use thorough medication reconciliation at the pharmacy to reduce Yellow Card reports of sedation and confusion with combined depressant therapy.

Cultural Perceptions And Patient Habits

Patients often describe Phenergan as a “strong” antihistamine that reliably knocks down nausea and helps sleep during travel.

Online forums such as Patient.info and Mumsnet commonly report Phenergan in travel kits for motion sickness and as short‑term night‑time relief for nausea.

Community pharmacists in Boots, LloydsPharmacy and Superdrug are a trusted source of advice on sedating antihistamines and drug interactions.

Growth in online pharmacies and EPS e‑prescribing has improved access, but patients express concerns about authenticity and reduced side‑effect counselling when purchasing online.

• Common Patient Behaviours:
• Keeping Phenergan in a travel kit for nausea.
• Using it as a short‑term sleep aid while away from home.
• Asking pharmacists for advice about mixing with alcohol or other medicines.

Pharmacist counselling remains key to safe use and to counter misunderstandings about paediatric and elderly risks.

Availability And Pricing Patterns

Patients want to know where and how quickly they can get Phenergan and how much it costs.

Phenergan/promethazine is prescription only in the UK according to product information and market classification.

High‑street pharmacies such as Boots, LloydsPharmacy and Superdrug dispense branded Phenergan and generics, while online pharmacies increasingly list promethazine with prescription verification via EPS.

England charges the standard prescription fee unless a patient is exempt, while Scotland, Wales and Northern Ireland generally provide free prescriptions — this creates a regional cost difference for repeat prescriptions.

Private prices vary by brand, pack size and supplier.

In our online pharmacy, phenergan is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Preferences

Clinicians will often choose alternatives to promethazine when sedation or anticholinergic burden is a concern.

Common alternative sedating antihistamines include chlorphenamine and diphenhydramine, while non‑sedating options include cetirizine and loratadine which are preferred for daily allergy control.

For motion sickness, cyclizine or specialist antiemetics such as ondansetron may be preferred in certain settings.

Use the pros/cons checklist to weigh nausea control against sedation and anticholinergic effects when advising patients.

Frequently Asked Questions

Q: Can I take Phenergan while pregnant or breastfeeding?

A: Only on clinician advice after a risk–benefit review with prescriber and pharmacist.

Q: Is promethazine safe for children?

A: It is not recommended under two years due to risk of fatal respiratory depression; older children require specialist dosing advice and close supervision.

Q: Can I drive after taking promethazine?

A: Avoid driving or operating machinery while sedated; promethazine commonly causes drowsiness and impairs reactions.

Q: What if I miss a dose or someone overdoses?

A: If you miss a dose, take it when remembered unless the next dose is due — do not double up.

A: In overdose, seek emergency care immediately; signs include severe CNS depression and anticholinergic effects and can be fatal, especially in children.

For up‑to‑date patient leaflets consult NHS pages and MHRA guidance or ask your pharmacist for printed information.

Guidelines For Proper Use

Patients expect clear, practical advice at the pharmacy counter.

Pharmacist counselling should follow an NHS‑style checklist: confirm prescription legitimacy, review current medicines for CNS depressants or MAOI use, advise on sedation and driving, and note paediatric and elderly cautions.

Set a clear stop or review date when prescribing short courses and advise on recording side effects via the MHRA Yellow Card scheme.

Storage guidance: store below 30°C, protect tablets from direct light, keep elixir tightly sealed and out of reach of children.

• Pharmacist Counselling Checklist:
• Confirm prescription and indication.
• Medication reconciliation for interactions.
• Advise on sedation, alcohol avoidance and driving.
• Provide follow‑up and MHRA Yellow Card reporting links.

Use a simple patient handout template listing dose, common side effects, when to seek help and storage advice at dispensing.

Delivery Across United Kingdom